Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Aug;64(4):537-545.
doi: 10.1111/1754-9485.13038. Epub 2020 May 14.

Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer

Collaborators, Affiliations
Multicenter Study

Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer

Anne Miles et al. J Med Imaging Radiat Oncol. 2020 Aug.

Abstract

Introduction: Whole body magnetic resonance imaging (WB-MRI) may be more efficient in staging cancers, but can be harder for patients to tolerate. We examined predictors of patient preference for WB-MRI vs. CT/ PET-CT for staging colorectal or lung cancer.

Methods: Patients recruited prospectively to two multicentre trials comparing diagnostic accuracy of WB-MRI with standard staging scans were sent two questionnaires: the first, administered at trial registration, captured demographics, educational level and comorbidities; the second, administered after staging completion, measured emotional distress (GHQ-12), positive mood (PANAS), perceived scan burden, patients' beliefs about WB-MRI, and preference for either WB-MRI or CT (colorectal trial), WB-MRI or PET-CT (lung trial). Preference for WB-MRI or CT/ PET-CT was analysed using logistic regression.

Results: Baseline and post-staging questionnaires were completed by 97 and 107 patients, respectively. Overall, 56/107 (52%) preferred WB-MRI over standard scans and were more likely to have no additional comorbidities, higher positive mood, greater awareness of potential benefits of WB-MRI and lower levels of perceived WB-MRI scan burden. In adjusted analyses, only awareness of potential WB-MRI benefits remained a significant predictor (OR: 1.516, 95% CIs 1.006-2.284, P = 0.047). Knowledge that WB-MRI does not use radiation predicted preference (adjusted OR: 3.018, 95% CIs 1.099-8.288, P = 0.032), although only 45/107 (42%) patients were aware of this attribute.

Conclusions: A small majority of patients undergoing staging of colorectal or lung cancer prefer WB-MRI to CT/ PET-CT. Raising awareness of the potential benefits of WB-MRI, notably lack of ionizing radiation, could influence preference.

Keywords: X-ray computed; cancer; magnetic resonance imaging; patient preference; positron emission tomography; tomography.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow diagram of participants through the study (March 2013–July 2015).

References

    1. Pierce DA, Preston DL. Radiation‐related cancer risks at low doses among atomic bomb survivors. Radiat Res 2000; 154: 178–86. - PubMed
    1. Kim HS, Lee KS, Ohno Y, van Beek EJ, Biederer J. PET/CT Versus MRI for Diagnosis, Staging, and Follow‐Up of Lung Cancer. J Magn Reson Imaging 2015; 42: 247–60. - PubMed
    1. National Institute for Health and Care Excellence . Myeloma: diagnosis and management. NICE guideline [NG35]. (Updated 2018 October; cited 19 September 2019). Available from: https://www.nice.org.uk/guidance/ng35/chapter/Recommendations#imaging‐in....
    1. Taylor SA, Mallett S, Beare Set al. Diagnostic accuracy of whole‐body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial. Lancet Gastroenterol Hepatol 2019; 4: 529–37. - PMC - PubMed
    1. Taylor SA, Mallett S, Ball Set al. Diagnostic accuracy of whole‐body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non‐small‐cell lung cancer: the prospective Streamline L trial. Lancet Respir Med 2019; 7: 523–32. - PMC - PubMed

Publication types

MeSH terms